Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

New antihypertensive agents from Banyu

Dec. 16, 1996

Nortran's antiarrhythmic agents receive patent protection

Dec. 13, 1996

Ivax generic cardiovascular drug approved in U.S.

Dec. 13, 1996

New ET antagonist in preclinical testing at Parke-Davis

Dec. 13, 1996

PLC Systems allowed to expand Heart Laser trials

Dec. 13, 1996

Antihypertensive peptides disclosed by Snow Brand

Dec. 13, 1996

Roussel Uclaf reports new quinoline derivatives

Dec. 13, 1996

Millennium/Lilly's gene-based assay for atherosclerosis

Dec. 12, 1996

NOS inhibitors described by Searle

Dec. 12, 1996

Therapeutically active NPY analog reported by academic source

Dec. 9, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 19, 2025.
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...
ASH 2025: Ianalumab data offer break from chronic ITP therapy
BioWorld
Novartis AG’s monoclonal antibody, ianalumab (VAY-736), when added to standard-of-care eltrombopag, extended disease control of primary immune thrombocytopenia...